Why More Doctors Are Prescribing Intuniv for Add over Classic Stimulants
Guanfacine extended-release is an essential psychiatric asset, but it is not a universal replacement for stimulants. Precision prescribing requires parsing patient traits to identify clear indications and active contraindications.
Ideal Profiles for Intuniv Therapy:
- Patients with High Emotional Lability or Tics: Children and adults whose ADHD manifests primarily as explosive frustration, low frustration tolerance, or who possess co-morbid motor tics that stimulants aggravate.
- Individuals with High Cardiovascular Baseline Risk: Patients who suffer from resting tachycardia, elevated blood pressure, or extreme physiological anxiety responses to caffeine and amphetamines.
- Patients Requiring Continuous 24-Hour Coverage: Individuals who wake up overwhelmed or experience severe behavioral volatility the moment their evening stimulant clears their system.
- Those with a History of Substance Misuse: Patients seeking an unscheduled, non-habit-forming medication that can be refilled without monthly DEA regulatory friction.
Profiles That Should Exercise Extreme Caution or Avoid Intuniv:
- Individuals Prone to Severe Bradycardia or Hypotension: Patients with baseline low blood pressure, a history of vasovagal fainting episodes, or autonomic balance issues like postural orthostatic tachycardia syndrome (POTS).
- Patients Battling Severe Hypersomnia or Depression: Individuals whose primary ADHD struggle is chronic under-arousal, brain fog, lethargy, and excessive sleep; Intuniv's sedative baseline may deepen fatigue.
- Unreliable Medication Adherents: People who frequently forget pills for two or three days running. As noted, abrupt cessation carries real risks of sudden rebound hypertension.
Tags:
